What is Gabbi?
Founded in 2019 and headquartered in Portland, Oregon, Gabbi operates at the intersection of clinical decision support and patient advocacy. The company was established by Kaitlin Christine following a personal loss to breast cancer, identifying a systemic failure in how healthcare providers evaluate and educate patients. Gabbi addresses the pervasive issue of information overload and the marginalization of women's health concerns by providing a streamlined, evidence-based platform. By synthesizing complex medical data into actionable insights, the company empowers users to navigate their health journeys with greater clarity and confidence, effectively bridging the communication gap between patients and clinical professionals.
How much funding has Gabbi raised?
Gabbi has raised a total of $1M across 1 funding round:
Unspecified
$1M
Unspecified (2021): $1M, investors not publicly disclosed
Key Investors in Gabbi
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Gabbi?
With this major strategic investment, Gabbi is poised to accelerate its operational scaling and enhance its proprietary diagnostic algorithms. The company is expected to focus on expanding its clinical partnerships and refining its digital interface to better serve a broader demographic of women. As the firm transitions into a more mature enterprise-level phase, the focus will likely shift toward integrating its platform into existing healthcare ecosystems, thereby standardizing the delivery of personalized risk assessments. This capital infusion provides the necessary runway to solidify Gabbi's market position as a leader in proactive, patient-centric health technology, ultimately aiming to improve long-term health outcomes through early detection and informed decision-making.
See full Gabbi company page
